ScienceDaily (Feb. 10, 2010) — Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
The scientists robotically "fired" 2,000 compounds into culture plates containing tumor cells to see if the compounds had any effect. When the robotic screener found one substance had scored a hit by inhibiting growth of the tumor cells in its plate,...
ScienceDaily (Jan. 27, 2010) — Childhood cancer survivors who had brain or other central nervous system cancers, or leukemia, achieve lower-than-expected educational success compared with the general public, according to an article published online January 27 in the Journal of the National Cancer Institute.
This study was undertaken because previous studies on educational attainment among childhood cancer survivors were small, had contradictory findings, or were not population-based....
ProCure Proton Therapy Center in Oklahoma City Treating Pediatric Patients
OKLAHOMA CITY--(BUSINESS WIRE)--Children with cancer are now being accepted for treatment at the ProCure Proton Therapy Center in Oklahoma, where a wide range of tumors are treated with proton therapy, an alternative to X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.
Teresa J. Vietti, M.D., a pediatric oncologist who earned the nickname “the mother of pediatric cancer therapy,” died Monday, Jan. 25, 2010, of natural causes in St. Louis. She was 82.
Vietti, professor emeritus of pediatrics and of radiology, was an internationally renowned pioneer of pediatric cancer research and treatment for more than 40 years. She conceived the concept of multi-institution...
Scientists at the University of Toronto and the Hospital for Sick Children (SickKids) have discovered a powerful new tool that can help predict the prognosis for patients with bone cancer and help doctors more accurately determine how aggressively they need to treat specific patients. They found that the presence of a specific type of genetic mutation found in the tumours...
